[ Price : $8.95]
Federal Register final order: FDA exempts from premarket notification requirements autosomal recessive carrier screening gene muta...[ Price : $8.95]
FDA denies a Millennial Pharmaceuticals petition seeking to put limits on ANDA or 505(b)(2) applications referencing its Velcade.[ Price : $8.95]
FDA Oncology Center of Excellence staffers say they are optimistic about the future of oncology drug development after approving t...[ Price : $8.95]
FDA lifts its clinical hold on a Cellectis investigational cancer drugs Phase 1 trials.[ Price : $8.95]
FDA releases its latest batch of Warning Letters that includes Biomin Industries and Guangdong Zhanjiang Jimin Pharmaceutical Co.[ Price : $8.95]
A JAMA viewpoint piece urges medical journal editors to encourage study authors to disclose CDRHs role in clinical trial design an...[ Price : $8.95]
FDA posts a guidance on Recommended Statement for Over-the-Counter Aspirin-Containing Drug Products Labeled With Cardiovascular Re...[ Price : $8.95]
FDA releases a guidance on Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment.